Apollo and Oxford University enter drug discovery and development collaboration
The latest collaboration marks Apollo’s sixth agreement with a research institution
Read More
Author: Jen Brogan
Study reveals new insights into ‘gene misbehaviour’ in healthy populations
The findings could support investigations into human genetics and various complex diseases
Read More
HDR UK and DPUK granted £2m for new motor neurone disease research initiative
The rapidly progressive neurological condition affects around 5,000 people in the UK
Read More
Study finds 3D-printed blood vessels could improve heart bypass outcomes
Coronary heart disease is the most common form of heart and circulatory disease
Read More
MIT study reveals how specific cells in AD become vulnerable and resilient
The neurodegenerative condition is recognised as the most common form of dementia
Read More- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
